Plasma GLP-1 levels increase following oral glucose or meal ingestion, but not after intravenous glucose administration, suggesting the circulating peptide is largely gut-derived [32], whereas islet GLP-1 production has largely been reported in models of inflammation and diabetes [17, 33]. The gene discussed is GCG; the disease is diabetes mellitus.